NCT05407324Phase 2Active not recruiting

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

Study sponsor: Corcept Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-10Estimated
Enrollment · participants279Estimated
Source updated2026-09-24Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Primary completion date changed

Before: Sep 2026. After: Oct 2026.

Check registry source

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Recruiting.

Check registry source

· 5 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from Baseline to Week 24 in the ALS Functional Rating Scale-Revised (ALSFRS-R) total score. Measure: Incidence of Adverse Events (AEs), Serious Adverse Events (SAEs), treatment-related AEs, AEs by severity, and deaths due to AEs.. After: Measure: Change from Baseline to Week 24 in the ALS Functional Rating Scale-Revised (ALSFRS-R) total score. Measure: Incidence of Adverse Events (AEs), Serious Adverse Events (SAEs), treatment-related AEs, AEs by severity, and deaths due to AEs Measure: Incidence of treatment-emergent AEs and SAEs Measure: Incidence of treatment-emergent AEs leading to dose interruptions, dose reductions, and/or discontinuations of study drug.

Participant count type changed

Before: Actual. After: Estimated.

Enrollment · participant count changed

Before: 249 participants (actual). After: 279 participants (planned).

Completion date type changed

Before: Actual. After: Estimated.

Primary completion date changed

Before: 22 Oct 2024. After: Sep 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview